These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 28344893)
1. Integrated analysis of somatic mutations and immune microenvironment in malignant pleural mesothelioma. Kiyotani K; Park JH; Inoue H; Husain A; Olugbile S; Zewde M; Nakamura Y; Vigneswaran WT Oncoimmunology; 2017; 6(2):e1278330. PubMed ID: 28344893 [TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of somatic mutations and immune microenvironment of multiple regions in breast cancers. Kato T; Park JH; Kiyotani K; Ikeda Y; Miyoshi Y; Nakamura Y Oncotarget; 2017 Sep; 8(37):62029-62038. PubMed ID: 28977923 [TBL] [Abstract][Full Text] [Related]
3. Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma. de Perrot M; Wu L; Cabanero M; Perentes JY; McKee TD; Donahoe L; Bradbury P; Kohno M; Chan ML; Murakami J; Keshavjee S; Tsao MS; Cho BCJ J Thorac Cardiovasc Surg; 2020 May; 159(5):2082-2091.e1. PubMed ID: 31866087 [TBL] [Abstract][Full Text] [Related]
4. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time. Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216 [TBL] [Abstract][Full Text] [Related]
5. Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns. Li Z; Chen G; Cai Z; Dong X; He L; Qiu L; Zeng Y; Liu X; Liu J Chin J Cancer Res; 2021 Jun; 33(3):364-378. PubMed ID: 34321833 [TBL] [Abstract][Full Text] [Related]
6. Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma. Patil NS; Righi L; Koeppen H; Zou W; Izzo S; Grosso F; Libener R; Loiacono M; Monica V; Buttigliero C; Novello S; Hegde PS; Papotti M; Kowanetz M; Scagliotti GV J Thorac Oncol; 2018 Jan; 13(1):124-133. PubMed ID: 29079455 [TBL] [Abstract][Full Text] [Related]
7. Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment. Chen R; Lee WC; Fujimoto J; Li J; Hu X; Mehran R; Rice D; Swisher SG; Sepesi B; Tran HT; Chow CW; Little LD; Gumbs C; Haymaker C; Heymach JV; Wistuba II; Lee JJ; Futreal PA; Zhang J; Reuben A; Tsao AS; Zhang J Clin Cancer Res; 2020 Oct; 26(20):5477-5486. PubMed ID: 32816946 [TBL] [Abstract][Full Text] [Related]
18. T cell receptor β-chain repertoire analysis reveals the association between neoantigens and tumour-infiltrating lymphocytes in multifocal papillary thyroid carcinoma. Lu Z; Zhang C; Sheng J; Shen J; Liu B Int J Cancer; 2017 Jul; 141(2):377-382. PubMed ID: 28431188 [TBL] [Abstract][Full Text] [Related]
19. Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas. Kang HC; Kim HK; Lee S; Mendez P; Kim JW; Woodard G; Yoon JH; Jen KY; Fang LT; Jones K; Jablons DM; Kim IJ Oncotarget; 2016 Feb; 7(7):8321-31. PubMed ID: 26824986 [TBL] [Abstract][Full Text] [Related]
20. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer. Strickland KC; Howitt BE; Shukla SA; Rodig S; Ritterhouse LL; Liu JF; Garber JE; Chowdhury D; Wu CJ; D'Andrea AD; Matulonis UA; Konstantinopoulos PA Oncotarget; 2016 Mar; 7(12):13587-98. PubMed ID: 26871470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]